Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical companies, which includes the makers of Xarelto, have a duty to make sure that their drugs are reasonably protected for use – and failure to complete so may possibly be grounds for compensation. Our lawyers are working hard to obtain those hurt by the drug the compensation they are entitled to.
Whilst bleeding can be a widespread complication connected with anticoagulants, it has been alleged that Xarelto is more dangerous than classic blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, in the occasion of an emergency, sufferers could be at risk for irreversible bleeding problems, which includes life-threatening internal and gastrointestinal hemorrhaging.
In case you or possibly a loved 1 suffered a significant bleeding event after taking Xarelto, you wiki.lacisnenegro.org might have legal recourse. For more info, contact us right now to possess your case reviewed, totally free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future health-related bills, lost wages, discomfort and suffering and, in cases of death, funeral expenditures. Additionally, they are searching for punitive damages, that are generally awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.
Visit this page for more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.